Bionomics Ltd. ADR (NASDAQ:BNOX)’s traded shares stood at 15.47 million during the last session, with the company’s beta value hitting -0.16. At the close of trading, the stock’s price was $0.36, to imply an increase of 22.57% or $0.07 in intraday trading. The BNOX share’s 52-week high remains $3.74, putting it -938.89% down since that peak but still an impressive 36.11% since price per share fell to its 52-week low of $0.23. The company has a valuation of $4.77M, with an average of 1.93 million shares in intraday trading volume over the past 10 days and average of 626.62K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Bionomics Ltd. ADR (BNOX), translating to a mean rating of 1.00. Of 3 analyst(s) looking at the stock, 0 analyst(s) give BNOX a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 3 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bionomics Ltd. ADR (NASDAQ:BNOX) trade information
After registering a 22.57% upside in the last session, Bionomics Ltd. ADR (BNOX) has traded red over the past five days. The 5-day price performance for the stock is 32.63%, and -43.73% over 30 days. With these gigs, the year-to-date price performance is -75.67%. Short interest in Bionomics Ltd. ADR (NASDAQ:BNOX) saw shorts transact 72985.0 shares and set a 0.46 days time to cover.
The extremes give us $6 and $6 for target low and target high price respectively. As such, BNOX has been trading -1566.67% off suggested target high and -1566.67% from its likely low.
Bionomics Ltd. ADR (BNOX) estimates and forecasts
Looking at statistics comparing Bionomics Ltd. ADR share performance against respective industry, we note that the company has outperformed competitors. Bionomics Ltd. ADR (BNOX) shares are -62.73% down over the last 6 months, with its year-to-date growth rate higher than industry average at 18.08% against 17.50%.
BNOX Dividends
Bionomics Ltd. ADR has its next earnings report out in November. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is LYNX1 CAPITAL MANAGEMENT LP with 0.6 million shares, or about 6.3212% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.46 million.
